Print Page

Other safety alerts

 
Australia: TGA warns about imports of ivermectin
 
The Therapeutic Goods Administration (TGA) announces that it has tested a number of imported products labelled as ivermectin and found that they are counterfeit under the Therapeutic Goods Act 1989. Laboratory testing has confirmed that the following 12mg products contain less than the active pharmaceutical ingredient declared on the labels:
- Iversun-12
- Covimectin-12
- Ivilife-12

The results of the TGA testing serve as a warning against buying ivermectin products from unverified online sellers. Counterfeit products may contain undeclared and hazardous ingredients that could cause a serious adverse reaction. They may also be contaminated because of a lack of manufacturing and testing standards.

The TGA strongly discourages self-medication and self-dosing for the treatment or prevention of COVID-19. It is very dangerous to take large doses of ivermectin and there is insufficient evidence to validate its safe and effective use for COVID-19.

Please refer to the following website in TGA for details: http://www.tga.gov.au/media-release/tga-warns-about-imports-ivermectin

In Hong Kong, the above products are not registered pharmaceutical products.

Ends/Tuesday, Dec 14, 2021
Issued at HKT 15:00
 
Related Information:
Australia: Safety advisory: Iverjohn-12 & Ivervid-12 tablets Posted 2025-06-25
Australia: Continuing imports of counterfeit ivermectin Posted 2024-10-28
Australia: TGA cautions consumers over counterfeit ivermectin Posted 2022-03-04
 
back